These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17170199)

  • 21. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
    Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
    J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.
    Hanessian S; Charron G; Billich A; Guerini D
    Bioorg Med Chem Lett; 2007 Jan; 17(2):491-4. PubMed ID: 17070046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.
    Guerrero M; Poddutoori R; Urbano M; Peng X; Spicer TP; Chase PS; Hodder PS; Schaeffer MT; Brown S; Rosen H; Roberts E
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6346-9. PubMed ID: 24135724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
    Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
    BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation-independent internalisation and desensitisation of the human sphingosine-1-phosphate receptor S1P3.
    Rutherford C; Ord-Shrimpton FU; Sands WA; Pediani JD; Benovic JL; McGrath JC; Palmer TM
    Cell Signal; 2005 Aug; 17(8):997-1009. PubMed ID: 15894172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design.
    Tian Y; Jin J; Wang X; Hu J; Xiao Q; Zhou W; Chen X; Yin D
    Eur J Med Chem; 2014 Oct; 85():1-15. PubMed ID: 25072873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists.
    Colandrea VJ; Legiec IE; Huo P; Yan L; Hale JJ; Mills SG; Bergstrom J; Card D; Chebret G; Hajdu R; Keohane CA; Milligan JA; Rosenbach MJ; Shei GJ; Mandala SM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2905-8. PubMed ID: 16580205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of S1P agonists with a dihydronaphthalene scaffold.
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Takada Y; Shioya H; Komiya T; Mizuno H; Ono T; Hagiya H; Minami M; Nakade S; Habashita H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3885-9. PubMed ID: 21641216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No differences observed among multiple clinical S1P1 receptor agonists (functional antagonists) in S1P1 receptor down-regulation and degradation.
    Lukas S; Patnaude L; Haxhinasto S; Slavin A; Hill-Drzewi M; Horan J; Modis LK
    J Biomol Screen; 2014 Mar; 19(3):407-16. PubMed ID: 24003058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.
    Piali L; Froidevaux S; Hess P; Nayler O; Bolli MH; Schlosser E; Kohl C; Steiner B; Clozel M
    J Pharmacol Exp Ther; 2011 May; 337(2):547-56. PubMed ID: 21345969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes.
    Bolli MH; Müller C; Mathys B; Abele S; Birker M; Bravo R; Bur D; Hess P; Kohl C; Lehmann D; Nayler O; Rey M; Meyer S; Scherz M; Schmidt G; Steiner B; Treiber A; Velker J; Weller T
    J Med Chem; 2013 Dec; 56(23):9737-55. PubMed ID: 24266709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of new ligands for targeting the S1P1 receptor.
    Schilson SS; Keul P; Shaikh RS; Schäfers M; Levkau B; Haufe G
    Bioorg Med Chem; 2015 Mar; 23(5):1011-26. PubMed ID: 25656338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel S1P(1) receptor agonists--part 3: from thiophenes to pyridines.
    Bolli MH; Abele S; Birker M; Bravo R; Bur D; de Kanter R; Kohl C; Grimont J; Hess P; Lescop C; Mathys B; Müller C; Nayler O; Rey M; Scherz M; Schmidt G; Seifert J; Steiner B; Velker J; Weller T
    J Med Chem; 2014 Jan; 57(1):110-30. PubMed ID: 24367923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
    Ha SN; Hey PJ; Ransom RW; Bock MG; Su DS; Murphy KL; Chang R; Chen TB; Pettibone D; Hess JF
    Biochemistry; 2006 Dec; 45(48):14355-61. PubMed ID: 17128974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
    González-Díez M; Rodríguez C; Badimon L; Martínez-González J
    Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.
    Sanna MG; Liao J; Jo E; Alfonso C; Ahn MY; Peterson MS; Webb B; Lefebvre S; Chun J; Gray N; Rosen H
    J Biol Chem; 2004 Apr; 279(14):13839-48. PubMed ID: 14732717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor.
    van Loenen PB; de Graaf C; Verzijl D; Leurs R; Rognan D; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2011 Sep; 667(1-3):105-12. PubMed ID: 21663738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
    Sanna MG; Wang SK; Gonzalez-Cabrera PJ; Don A; Marsolais D; Matheu MP; Wei SH; Parker I; Jo E; Cheng WC; Cahalan MD; Wong CH; Rosen H
    Nat Chem Biol; 2006 Aug; 2(8):434-41. PubMed ID: 16829954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.